Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial.

Lingvay, Ildiko; Harris, Stewart; Jaeckel, Elmar; Chandarana, Keval; Ranthe, Mattis F; Jódar, Esteban.
Diabetes Obes Metab; 20(1): 200-205, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28643425